Signal active
Organization
Contact Information
Overview
Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS.
Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
About
Biotechnology, Health Care, Medical, Genetics
2006
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Precision BioSciences headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Genetics sector. The company focuses on Biotechnology and has secured $25.5B in funding across 96 round(s). With a team of 101-250 employees, Precision BioSciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Precision BioSciences, raised $25.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
6
9
0
$265.1M
Details
3
Precision BioSciences has raised a total of $265.1M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Early Stage Venture | 110.0M | ||
2006 | Seed | |||
2015 | Early Stage Venture | 25.6M |
Investors
Precision BioSciences is funded by 41 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
The Longevity Fund | - | FUNDING ROUND - The Longevity Fund | 25.6M |
Eight Roads Ventures | - | FUNDING ROUND - Eight Roads Ventures | 25.6M |
Precision BioSciences | - | FUNDING ROUND - Precision BioSciences | 25.6M |
Ziegler Link-Age Funds | - | FUNDING ROUND - Ziegler Link-Age Funds | 25.6M |
Recent Activity
There is no recent news or activity for this profile.